EyePoint (EYPT) Current Leases (2019)

EyePoint (EYPT) posted Current Leases of $481000.0 for Q4 2019, up 4.34% sequentially from $461000.0 in Q3 2019.

EyePoint (EYPT) Current Leases (2019) Analysis & Trends

EyePoint has reported Current Leases for 1 years, with the latest figure at $481000.0 in Q4 2019.

Quarterly Current Leases changed N/A year-over-year to $481000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $481000.0 (changed N/A YoY) and the FY2019 annual result came in at $481000.0, changed N/A from the prior year.
Current Leases rose to $481000.0 in Q4 2019 per EYPT's latest filing, from $461000.0 in the prior quarter.
Over five years, Current Leases peaked at $481000.0 in Q4 2019 and troughed at $417000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	11.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	16.75 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	21.95 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	2.24 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	45.93 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.27 Mn
10	EyePoint	1.25 Bn	1.07 Bn	507,000.00	-

Download Data